Extracellular high-mobility group box 1 acts as an innate immune mediator to enhance autoimmune progression and diabetes onset in NOD mice
about
Disruption of a Regulatory Network Consisting of Neutrophils and Platelets Fosters Persisting Inflammation in Rheumatic DiseasesTrauma equals danger--damage control by the immune systemHMGB1 conveys immunosuppressive characteristics on regulatory and conventional T cellsThe dendritic cell response to classic, emerging, and homeostatic danger signals. Implications for autoimmunityThe role of dendritic cells in autoimmunityLoss of Jak2 selectively suppresses DC-mediated innate immune response and protects mice from lethal dose of LPS-induced septic shock.HMGB1 in health and disease.Comparative analysis of the alveolar macrophage proteome in ALI/ARDS patients between the exudative phase and recovery phase.Low shear stress induced HMGB1 translocation and release via PECAM-1/PARP-1 pathway to induce inflammation responseT cell-driven initiation and propagation of autoimmune diabetesThe Free Radical Scavenger NecroX-7 Attenuates Acute Graft-versus-Host Disease via Reciprocal Regulation of Th1/Regulatory T Cells and Inhibition of HMGB1 Release.Relationship of Soluble RAGE with Insulin Resistance and Beta Cell Function during Development of Type 2 Diabetes Mellitus.The role of endoplasmic reticulum stress in autoimmune-mediated beta-cell destruction in type 1 diabetes.Cx3cr1 deficiency in mice attenuates hepatic granuloma formation during acute schistosomiasis by enhancing the M2-type polarization of macrophagesNO donor induces Nec-1-inhibitable, but RIP1-independent, necrotic cell death in pancreatic β-cells.Toll-like receptor 4 on islet β cells senses expression changes in high-mobility group box 1 and contributes to the initiation of type 1 diabetesChop deficiency prevents UUO-induced renal fibrosis by attenuating fibrotic signals originated from Hmgb1/TLR4/NFκB/IL-1β signaling.AAL exacerbates pro-inflammatory response in macrophages by regulating Mincle/Syk/Card9 signaling along with the Nlrp3 inflammasome assembly.Transcriptomic analysis of the effects of Toll-like receptor 4 and its ligands on the gene expression network of hepatic stellate cellsProtective Effect of an Antibody against Specific Extracellular Domain of TLR2 on Agonists-Driven Inflammatory and Allergic ResponseSUMO1 regulates endothelial function by modulating the overall signals in favor of angiogenesis and homeostatic responsesHMGB1 exacerbates bronchiolitis obliterans syndrome via RAGE/NF-κB/HPSE signaling to enhance latent TGF-β release from ECM.HMGB1, an innate alarmin, in the pathogenesis of type 1 diabetes.The Role of HMGB1 in the Pathogenesis of Type 2 Diabetes.Tim-1-Fc suppresses chronic cardiac allograft rejection and vasculopathy by reducing IL-17 productionPdx1 and other factors that regulate pancreatic beta-cell survival.HMGB1 is an early and critical mediator in an animal model of uveitis induced by IRBP-specific T cells.HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation.High-mobility group box-1 in sterile inflammation.How apoptotic β-cells direct immune response to tolerance or to autoimmune diabetes: a review.The influence of the telomere-telomerase system on diabetes mellitus and its vascular complications.Inhibition of high-mobility group box 1 expression by siRNA in rat hepatic stellate cellsReceptor for Advanced Glycation End Products (RAGE) in Type 1 Diabetes Pathogenesis.The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules.Niaspan reduces high-mobility group box 1/receptor for advanced glycation endproducts after stroke in type-1 diabetic ratsHigh-mobility group box 1 protein (HMGB1) neutralization ameliorates experimental autoimmune encephalomyelitis.Neutralization of the extracellular HMGB1 released by ischaemic damaged renal cells protects against renal ischaemia-reperfusion injury.High-mobility group box 1 promotes early acute allograft rejection by enhancing IL-6-dependent Th17 alloreactive response.Both conditional ablation and overexpression of E2 SUMO-conjugating enzyme (UBC9) in mouse pancreatic beta cells result in impaired beta cell function.Cellular death, reactive oxygen species (ROS) and diabetic complications.
P2860
Q26744644-86B1BFA1-8FD0-491E-BD48-B7FF0AA48D4EQ26860731-5B930DC3-7FBD-44C7-9AEB-74AA18ED919DQ28117763-03FCC3F2-8A53-4849-BCD2-D1E134C9C247Q28384138-305F2D8C-2FA0-499C-BDD9-594ABBC6E79BQ30047565-B82BAB92-1E6F-4E4A-8F0E-E5859F7F69F1Q33541021-61869198-4F52-4D23-B9F4-497B6E6ACEE6Q34622835-D42F3056-27C1-4605-B5AC-4D85078F3960Q34774988-85F63FE7-8FE3-48C3-B86A-1E72DF119E3BQ35582672-880561F0-9397-40A6-ACED-03D508074A08Q35597162-DC62436F-B8C8-42E2-BAE5-D191EB674FCBQ35609254-DE126828-081E-48F9-BDF0-8FD645DB9336Q35674689-6D323241-1945-43D2-9305-DFCE4E8667EEQ35791706-0CD71110-DEE6-4D92-8EC5-100DF680CFB3Q35802861-7C78C905-1F7A-481C-9C2D-A176DBE016D6Q35832660-FC02AE97-F127-4B51-8B36-E68AD13986D0Q35952134-3E9975BF-DC72-4312-88A0-D89C51626A85Q36022252-584A5F59-226B-4D4F-B8A3-95FE20D82FD7Q36309480-8E93B223-0B6F-4AF0-AE5D-9226C684C374Q36596002-35C1FF5D-D93D-4820-9AC6-DB507B75E03DQ36880724-21B9B316-5650-44B8-BE58-BD7F85DD4857Q36881822-73367D53-D197-4168-9E7F-5FFCADA76946Q36964047-45A3D736-FE3E-4D63-BE05-EA7C9ED542C2Q37418804-B22E3FC7-4D8A-4541-9E62-0A28955F4EF2Q37560287-D2F3B4D5-6770-4875-8E9D-9C544D480EBDQ37587334-4DDFD920-2463-443D-B267-D935BD679AD0Q37611922-D20EB73D-7E20-47B2-9E20-0082E8F0E7E6Q37644976-39B3C01B-F0E2-46A1-898C-B65AC7108791Q37876420-5EEDDEA7-15B2-410F-9718-4F015D0A0B68Q38220792-072AA2BF-8419-44D2-A720-616F8631C737Q38325456-E23FCED6-52FC-4B6F-8D58-8A24EE720C90Q38353839-71C5BD2D-D634-47ED-99E5-3274E44EB52AQ38549556-41CBA6EB-2DF9-4734-B83D-75EF98B85607Q38950436-501F1775-57E7-4C7A-9693-2AF55C5CFD25Q39168114-2433CFC1-16E6-424D-AA15-4CAFCF9D8A64Q40478584-1C96F47C-F002-45E3-AE1C-6987626DD3A8Q41511974-3E36319D-C30A-420C-A567-31BD3E10394CQ44320666-B6913FE9-CE65-46A8-AA85-FE99E19DEB63Q45731737-4B6665C1-AE24-4F75-9AEC-7DA2A795E32BQ47233632-CC122461-1651-4913-9A2C-19CCE1EEB5F1Q49679592-F9C683EF-5276-4A44-A8B8-CCCD2DD3A34D
P2860
Extracellular high-mobility group box 1 acts as an innate immune mediator to enhance autoimmune progression and diabetes onset in NOD mice
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Extracellular high-mobility gr ...... and diabetes onset in NOD mice
@ast
Extracellular high-mobility gr ...... and diabetes onset in NOD mice
@en
type
label
Extracellular high-mobility gr ...... and diabetes onset in NOD mice
@ast
Extracellular high-mobility gr ...... and diabetes onset in NOD mice
@en
prefLabel
Extracellular high-mobility gr ...... and diabetes onset in NOD mice
@ast
Extracellular high-mobility gr ...... and diabetes onset in NOD mice
@en
P2093
P2860
P356
P1433
P1476
Extracellular high-mobility gr ...... and diabetes onset in NOD mice
@en
P2093
Cong-Yi Wang
David M Stern
Feili Gong
Jin-Xiong She
Junyan Han
Mong-Heng Wang
Sharad Purohit
Wenzhong Wei
Yafei Huang
P2860
P304
P356
10.2337/DB07-1499
P407
P50
P577
2008-05-13T00:00:00Z